News & Insights
Professionals
Focus Areas
Regions
Type
Sort By
Client News 1 result
Client News
|August 6, 2026
Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals
Tarsus Pharmaceuticals announces its definitive agreement to acquire Alkeus Pharmaceuticals, a privately held retinal disease-focused biotechnology company developing gildeuretinol (ALK-001), an investigational once-daily oral therapy for Stargardt disease.